KEROS THERAPEUTICS INC Share Price Today: Live Updates & Key Insights
KEROS THERAPEUTICS INC share price today is $10.96, up -1.44%. The stock opened at $11.005 against the previous close of $11.12, with an intraday high of $11.245 and low of $10.7.
KEROS THERAPEUTICS INC Share Price Chart
KEROS THERAPEUTICS INC
KEROS THERAPEUTICS INC Share Price Performance
KEROS THERAPEUTICS INC Institutional Holdings
KEROS THERAPEUTICS INC Market Status
KEROS THERAPEUTICS INC Fundamentals
Market Cap 333.91 M
PB Ratio 0.7233
PE Ratio 4.7652
Enterprise Value -54.63 M
Total Assets 338.02 M
Volume 2268579
KEROS THERAPEUTICS INC Company Financials
About KEROS THERAPEUTICS INC & investment objective
Company Information Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops and commercializes novel therapeutics to treat patients with disorders linked to dysfunctional signaling of the transforming growth factor-beta family of proteins in the United States. It develops rinvatercept, which acts as a ligand trap and inhibits the biological effects of myostatin and activin A in Phase 1 clinical trials for Duchenne Muscular Dystrophy and Amyotrophic Lateral Sclerosis; and elritercept to target TGF-ß signaling pathways to address diseases that arise from ineffective hematopoiesis in Phase 3 clinical trials for Myelodysplastic Syndromes and Phase 2 clinical trials for Myelofibrosis. The company has collaboration and license agreements with Hansoh (Shanghai) Healthtech Co., Ltd. to develop, manufacture, and commercialize elritercept and licensed products containing elritercept; and Takeda Pharmaceuticals U.S.A., Inc. to develop, manufacture, and commercialize elritercept and certain derivative compounds. Keros Therapeutics, Inc. was incorporated in 2015 and is headquartered in Lexington, Massachusetts.
Organisation Biotechnology
Employees 78
Industry Biotechnology
CEO Dr. Jasbir S. Seehra Ph.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
KEROS THERAPEUTICS INC FAQs
What is the share price of KEROS THERAPEUTICS INC today?
The current share price of KEROS THERAPEUTICS INC is $10.96.
Can I buy KEROS THERAPEUTICS INC shares in India?
Yes, Indian investors can buy KEROS THERAPEUTICS INC shares by opening an international trading and demat account with Motilal Oswal.
How to buy KEROS THERAPEUTICS INC shares in India?
You can easily invest in KEROS THERAPEUTICS INC shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy KEROS THERAPEUTICS INC shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of KEROS THERAPEUTICS INC.
Can I buy fractional shares of KEROS THERAPEUTICS INC?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of KEROS THERAPEUTICS INC?
KEROS THERAPEUTICS INC has a market cap of $333.91 M.
In which sector does KEROS THERAPEUTICS INC belong?
KEROS THERAPEUTICS INC operates in the Biotechnology sector.
What documents are required to invest in KEROS THERAPEUTICS INC stocks?
To invest, you typically need:
What is the PE and PB ratio of KEROS THERAPEUTICS INC?
The PE ratio of KEROS THERAPEUTICS INC is 4.77 and the PB ratio is 0.72.